CYHCommunity Health Systems, Inc.
Community Health Systems, Inc. (CYH) operates as a regional healthcare provider, offering inpatient and outpatient services through a network of hospitals and clinics. The next catalyst is Oct 29, 2026 — Q3 2026 Earnings Release, which will test the company’s ability to stabilize margins and deliver on its deleveraging plan amid ongoing reimbursement pressures.
- CYH reported $12.01B in revenue for the 2026 second quarter, but free cash flow remained negative at -$666M over the trailing twelve months.
- The company’s net margin of 3.5% is under pressure from rising labor costs and declining reimbursement rates.
- CYH’s debt-to-equity ratio of -7.69x suggests a highly leveraged balance sheet, with shareholders’ equity at -$1.39B.
The Read
CYH’s stock showed limited reaction to a Q4 2025 EPS beat offset by weak guidance, then rose about 3.
The schedule
- Thu29Oct
The earnings release will test the ability to maintain margins amid CMS reimbursement pressures, differing from the last print where revenue fell short due to lower inpatient volumes.
- Tue12Jan
The conference will test the stock's ability to reflect forward-looking guidance on cost containment and potential M&A activity, contrasting with the last event where the outlook was muted due to regulatory uncertainty.
- Sun14Feb
The earnings and guidance will test the ability to show improved operating leverage and margin expansion, differing from the last print where guidance was cut due to lower-than-expected inpatient revenue.
- Wed21Apr
The earnings release will test the ability to maintain margins amid CMS reimbursement pressures, differing from the last print where revenue fell short due to lower inpatient volumes.
- Thu29Jul
The earnings release will test the ability to maintain margins amid CMS reimbursement pressures, differing from the last print where revenue fell short due to lower inpatient volumes.
Past
- Tue15Sep
Actual outcome: Bear · $2.87 at outcome
The stock fell 3.5% following the non-core asset divestiture and debt reduction update, as investors reacted to the lack of progress on deleveraging and operational improvements. The outcome date price of $2.87 fell below the bear floor, indicating disappointment with the strategic update. While the news did not explicitly miss on earnings, the market viewed the update as underwhelming, leading to the decline.
Anticipated operational update on strategic asset sales aimed at deleveraging the balance sheet.
- Tue4Aug
Actual outcome: Bear · $3.00 at outcome
The CMS finalized its Inpatient Prospective Payment System (IPPS) rule, delivering Medicare reimbursement rate updates that fell short of hospital operators' expectations for offsetting persistent labor and operating cost inflation. While the stock saw a negligible initial uptick, the inadequate rate update failed to improve the company's margin outlook, keeping shares suppressed below the $3.10 bear floor.
Final Medicare reimbursement rate updates governing acute care hospital payments for the upcoming fiscal year.
- Thu30Jul
Actual outcome: Bear · $2.96 at outcome
Community Health Systems reported a wider-than-expected Q2 loss and missed revenue estimates, prompting a reduction in its full-year 2026 revenue, EBITDA, and earnings outlook. Management cited higher uninsured volumes, weaker elective surgical demand, and unfavorable payer mix trends as key headwinds. These deteriorating fundamentals and downgraded guidance kept the stock depressed well below the $3.35 bear floor, despite a minor upward drift in the days following the event.
Quarterly earnings report evaluating expense management and potential volume recovery against a heavy debt backdrop.
- Wed22Apr
Actual outcome: Bull · $2.79 at outcome
CYH reported an EPS actual of -4.57, matching the estimate, with no significant guidance changes. The stock rallied 3.0% post-earnings, driven by positive news surrounding the tender offer for senior secured notes, signaling potential capital restructuring and financial flexibility. The price movement aligned with the bull target, indicating market confidence in the company's strategic direction despite the earnings miss.
- Fri10Apr
Actual outcome: Bull · $3.15 at outcome
The stock maintained its elevated levels near the bull target following the expected release of the CMS IPPS proposed rule. While specific details of the Medicare reimbursement rates were not highlighted in the news, investor sentiment was bolstered by the company's ongoing strategic divestiture push, including the recent $459 million sale of its Crestwood Medical Center in Alabama to shed non-core facilities.
- Thu19Feb
Actual outcome: Mixed · $3.49 at outcome
CYH delivered a significant EPS beat by breaking even against expectations of a $0.32 loss, driven by successful expense management and reduced contract labor costs. However, the stock's momentum was stalled by weak 2026 guidance for revenue and EBITDA, as management warned of ongoing volume pressures that continue to weigh on the long-term growth outlook.
